Pharmaron (Stock Code: 300759.SZ/3759.HK) is a premier service provider for the life sciences industry. Founded in 2004, Pharmaron has invested in its people and facilities, and established a broad spectrum of research, development and manufacturing service capabilities throughout the entire drug discovery, preclinical and clinical development process across multiple therapeutic modalities, including small molecules, biologics and CGT products. With over 20,000 employees and operations in China, the U.S., and the U.K., Pharmaron has an excellent track record in the delivery of R&D solutions to its partners in North America, Europe, Japan and China. Services: * Synthetic, medicinal and analytical chemistry services * Biology services * DMPK services * Pharmacology services * Drug safety assessment services * Radiochemistry and isotopically labelled metabolism services * Chemical & pharmaceutical development services * Clinical development services www.pharmaron.com CRO - Contract Research Organization & CDMO - Contract Development Manufacturing Organization Library Synthesis CADD Bioorganic Chemistry Discovery Process Chemistry Radiolabelled Chemical Synthesis ChemInformatics in vitro Biology in vitro Screening Structural Biology in vivo Pharmacology Animal Disease Models ex vivo Pharmacology Biomarkers in vitro ADME in vivo PK PKPD QA Regulatory Affairs Discovery Biologics Process Chemistry API Manufacturing Material Science Formulation Development Drug Product Manufacturing Toxicology Safety Pharmacology Genetic Toxicology DART Pathology Immunotoxicity Bioanalytical 14C / Carbon-14 Radiosynthesis 3H / Tritium Radiosynthesis QWBA mARG Clinical AME Mass Balance Metabolite Profiling Microdosing Phase 0 Absolute Bioavailability DDI First-in-Human (FIH) Thorough QT(TQT) Ethnobridging
View Top Employees from PharmaronWebsite | http://www.pharmaron.com |
Revenue | $4.22 billion |
Funding | $320 million |
Employees | 1,760 (1,118 on RocketReach) |
Founded | 2003 |
Address | 6 Taihe Rd, Beijing 100176, CN |
Phone | +86 10 5733 0000 |
Technologies |
JavaScript,
HTML,
Google Analytics
+22 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Pharmaceuticals, Media and Information Services (B2B), Chemistry, Healthcare, Laboratory Services (Healthcare), Biology, DMPK, Pharmacology, Chemical Development, Preclinical, Toxicology, Safety Pharmacology, Discovery, Lead Optimization, Process Development, Assay Development, ADME, Formulation, IND |
Web Rank | 2 Million |
Keywords | Drug Development And Manufacturing |
Competitors | CMIC, Inc., Lambda Therapeutic Research, PPD, PSI CRO AG, Syngene -Clinical Development |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 541 Companies, NAICS Code 54171 Companies, NAICS Code 33 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies, NAICS Code 541711 Companies |
Looking for a particular Pharmaron employee's phone or email?
The Pharmaron annual revenue was $4.22 billion in 2024.
Rui Bin Wang is the Senior Vice President of Pharmaron.
1,118 people are employed at Pharmaron.
The NAICS codes for Pharmaron are [541, 54171, 33, 54, 5417, 541711].
The SIC codes for Pharmaron are [28, 283].